Collaborators from the Mayo Illinois Alliance for Technology Based Healthcare have developed a new, single molecule assay for detecting methylated DNA -- a naturally occurring process that controls gene expression. The assay involves using a synthetic solid-state nano pore, and researchers say it has great potential in speeding disease-specific analyses of genetic samples. The findings appear in the current issue of Scientific Reports (Nature Publishing Group).